Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sorrento gets Brazilian ANVISA’s clearance for Phase II Covid-19 trial

pharmaceutical-technologyMay 24, 2021

Tag: Sorrento , ANVISA , COVI-MSC , ARDS

PharmaSources Customer Service